Previous 10 | Next 10 |
The following slide deck was published by Celgene Corporation in conjunction with their 2018 Q4 earnings Read more ...
Celgene (NASDAQ: CELG ) Q4 results ($M): Revenue: 4,037 (+15.9%); product sales: 4,036 (+16.0%). More news on: Celgene Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Celgene (NASDAQ: CELG ): Q4 Non-GAAP EPS of $2.39 beats by $0.07 ; GAAP EPS of $1.50 misses by $0.27 . More news on: Celgene Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
By George P. Maris, CFA George Maris, Co-Head of Equities - Americas, discusses finding long-term value when short-term trends and rising rates disrupt markets in this second in a two-part series on volatility. George Maris: We've seen a dramatic change in the constituents that make ...
Celgene (NASDAQ: CELG ) is scheduled to announce Q4 earnings results on Thursday, January 31st, before market open. The consensus EPS Estimate is $2.32 (+16.0% Y/Y) and the consensus Revenue Estimate is $3.99B (+14.7% Y/Y). Over the last 2 years, CELG has beaten EPS estimates 100% of...
Deal Overview On January 3, 2019, Bristol-Meyers Squibb ( BMY ) announced it would acquire Celgene ( CELG ) in a stock and cash transaction. BMY is offering $50 cash, 1 share of BMY valued at $52.43 the day before announcement, and a contingent value right (“CVR”) worth $9 ca...
Merger activity decreased last week with one new deal announced and one pending deal closing. Deal Statistics: New Deals: The acquisition of UQM Technologies (UQM) by Danfoss Power Solutions (US) Company for $100 million or $1.71 per share in cash. Deal Updates: On Janua...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
Bristol-Myers ( BMY ) is a name which always can count on my attention, but even more so after the mega deal which it announced at the start of the year. I noted that investors did not like the $90 billion deal, as I ¨liked¨ the negative reaction in response to the deal, which ...
Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...